What are you looking for?

Need help finding what you are looking for? Contact Us

Compare

Free Samples

Home Market Research Reports Pharmaceutical

OTC Drug

PUBLISHER: QYResearch | PRODUCT CODE: 1875806

PUBLISHER: QYResearch | PRODUCT CODE: 1875806

Probiotics for Infants and Women - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

PUBLISHED: October 28, 2025

PAGES: 150 Pages

DELIVERY TIME: 2-3 business days

ADD TO COMPARE

SELECT AN OPTION

The global market for Probiotics for Infants and Women was estimated to be worth US$ 634 million in 2024 and is forecast to a readjusted size of US$ 1115 million by 2031 with a CAGR of 8.5% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Probiotics for Infants and Women cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

In the 21st century, advances in technologies such as genetic sequencing have greatly accelerated gut microbiome research. As a result, our understanding of the health benefits and mechanisms of probiotics has become more comprehensive. Probiotics-live microorganisms that are generally recognized as beneficial to the host-have emerged as one of the most prominent applied categories in life sciences. For infants, probiotics help quickly establish and maintain a healthy gut microbiota. The two major families of probiotics are Lactobacillus and Bifidobacterium. While Lactobacillus functions similarly in both adults and infants, Bifidobacterium plays a particularly crucial role in early childhood. In women's health, probiotic research primarily focuses on preventing and treating vaginitis and improving health during pregnancy and postpartum. Today, probiotics attract significant attention across ordinary foods, health supplements, and pharmaceuticals. This report focuses on probiotic powder ingredients for infants and women.

The market for probiotics tailored to infants and women is currently experiencing rapid growth. Rising health awareness and increasing consumer preference for natural and functional products are driving demand. In the maternal and infant product categories, probiotics have become a key functional ingredient, commonly added to infant formula, complementary foods, and probiotic drops. In women's health, probiotics are increasingly used in dietary supplements aimed at improving reproductive health and regulating the gut microbiota. The probiotic raw powder segment, as a critical upstream component, has attracted strong attention from both domestic and international brands. Market players include traditional fermentation enterprises, biotech firms, and multinational health companies, contributing to an increasingly competitive landscape. With continued progress in basic research, accumulation of clinical evidence, and ongoing consumer education, the probiotics market for infants and women is expected to evolve toward greater specialization and precision. Future products will emphasize clearly defined probiotic strains supported by scientific validation. Personalized nutrition solutions and scenario-specific product designs will become major development directions. Regulatory frameworks will also become more rigorous, pushing the industry from a concept-driven to a standard- and evidence-based model. Moreover, innovative delivery systems (such as time-release capsules and smart microencapsulation) and combination formulations (such as synbiotics) will enhance product form and user experience. Key market drivers include the broader trend of upgraded health consumption, the rigid demand among specific groups such as infants and women, and the growing acceptance of microbiome science in both medical and wellness contexts. Ongoing innovation and sustained industry investment are also injecting momentum into the sector. However, the industry still faces significant challenges, such as inconsistent consumer understanding of probiotic benefits, lack of standardized strain efficacy data, variability in raw material quality, and issues with misleading marketing and regulatory gaps. These factors undermine product credibility and market penetration, posing obstacles to future growth.

This report aims to provide a comprehensive presentation of the global market for Probiotics for Infants and Women, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Probiotics for Infants and Women by region & country, by Type, and by Application.

The Probiotics for Infants and Women market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Probiotics for Infants and Women.

Market Segmentation

By Company

DuPont
Novonesis
Lallemand
BioGaia
Probi
Biosearch Life
Morinaga Milk Industry
Synbio Tech
Kerry Group
Nestle
Yakult
Sabinsa
Evivo
AB-Biotics
Bioflag Group
Beijing Scitop Bio-tech
Hebei Yiran Biological Technology

Segment by Type

Lactobacillus
Bifidobacterium
Others

Segment by Application

Infant
Women

By Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Probiotics for Infants and Women manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Probiotics for Infants and Women in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Probiotics for Infants and Women in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

1 Market Overview

1.1 Probiotics for Infants and Women Product Introduction
1.2 Global Probiotics for Infants and Women Market Size Forecast
- 1.2.1 Global Probiotics for Infants and Women Sales Value (2020-2031)
- 1.2.2 Global Probiotics for Infants and Women Sales Volume (2020-2031)
- 1.2.3 Global Probiotics for Infants and Women Sales Price (2020-2031)
1.3 Probiotics for Infants and Women Market Trends & Drivers
- 1.3.1 Probiotics for Infants and Women Industry Trends
- 1.3.2 Probiotics for Infants and Women Market Drivers & Opportunity
- 1.3.3 Probiotics for Infants and Women Market Challenges
- 1.3.4 Probiotics for Infants and Women Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Probiotics for Infants and Women Players Revenue Ranking (2024)
2.2 Global Probiotics for Infants and Women Revenue by Company (2020-2025)
2.3 Global Probiotics for Infants and Women Players Sales Volume Ranking (2024)
2.4 Global Probiotics for Infants and Women Sales Volume by Company Players (2020-2025)
2.5 Global Probiotics for Infants and Women Average Price by Company (2020-2025)
2.6 Key Manufacturers Probiotics for Infants and Women Manufacturing Base and Headquarters
2.7 Key Manufacturers Probiotics for Infants and Women Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Probiotics for Infants and Women
2.9 Probiotics for Infants and Women Market Competitive Analysis
- 2.9.1 Probiotics for Infants and Women Market Concentration Rate (2020-2025)
- 2.9.2 Global 5 and 10 Largest Manufacturers by Probiotics for Infants and Women Revenue in 2024
- 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Probiotics for Infants and Women as of 2024)
2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type
- 3.1.1 Lactobacillus
- 3.1.2 Bifidobacterium
- 3.1.3 Others
3.2 Global Probiotics for Infants and Women Sales Value by Type
- 3.2.1 Global Probiotics for Infants and Women Sales Value by Type (2020 VS 2024 VS 2031)
- 3.2.2 Global Probiotics for Infants and Women Sales Value, by Type (2020-2031)
- 3.2.3 Global Probiotics for Infants and Women Sales Value, by Type (%) (2020-2031)
3.3 Global Probiotics for Infants and Women Sales Volume by Type
- 3.3.1 Global Probiotics for Infants and Women Sales Volume by Type (2020 VS 2024 VS 2031)
- 3.3.2 Global Probiotics for Infants and Women Sales Volume, by Type (2020-2031)
- 3.3.3 Global Probiotics for Infants and Women Sales Volume, by Type (%) (2020-2031)
3.4 Global Probiotics for Infants and Women Average Price by Type (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application
- 4.1.1 Infant
- 4.1.2 Women
4.2 Global Probiotics for Infants and Women Sales Value by Application
- 4.2.1 Global Probiotics for Infants and Women Sales Value by Application (2020 VS 2024 VS 2031)
- 4.2.2 Global Probiotics for Infants and Women Sales Value, by Application (2020-2031)
- 4.2.3 Global Probiotics for Infants and Women Sales Value, by Application (%) (2020-2031)
4.3 Global Probiotics for Infants and Women Sales Volume by Application
- 4.3.1 Global Probiotics for Infants and Women Sales Volume by Application (2020 VS 2024 VS 2031)
- 4.3.2 Global Probiotics for Infants and Women Sales Volume, by Application (2020-2031)
- 4.3.3 Global Probiotics for Infants and Women Sales Volume, by Application (%) (2020-2031)
4.4 Global Probiotics for Infants and Women Average Price by Application (2020-2031)

5 Segmentation by Region

5.1 Global Probiotics for Infants and Women Sales Value by Region
- 5.1.1 Global Probiotics for Infants and Women Sales Value by Region: 2020 VS 2024 VS 2031
- 5.1.2 Global Probiotics for Infants and Women Sales Value by Region (2020-2025)
- 5.1.3 Global Probiotics for Infants and Women Sales Value by Region (2026-2031)
- 5.1.4 Global Probiotics for Infants and Women Sales Value by Region (%), (2020-2031)
5.2 Global Probiotics for Infants and Women Sales Volume by Region
- 5.2.1 Global Probiotics for Infants and Women Sales Volume by Region: 2020 VS 2024 VS 2031
- 5.2.2 Global Probiotics for Infants and Women Sales Volume by Region (2020-2025)
- 5.2.3 Global Probiotics for Infants and Women Sales Volume by Region (2026-2031)
- 5.2.4 Global Probiotics for Infants and Women Sales Volume by Region (%), (2020-2031)
5.3 Global Probiotics for Infants and Women Average Price by Region (2020-2031)
5.4 North America
- 5.4.1 North America Probiotics for Infants and Women Sales Value, 2020-2031
- 5.4.2 North America Probiotics for Infants and Women Sales Value by Country (%), 2024 VS 2031
5.5 Europe
- 5.5.1 Europe Probiotics for Infants and Women Sales Value, 2020-2031
- 5.5.2 Europe Probiotics for Infants and Women Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
- 5.6.1 Asia Pacific Probiotics for Infants and Women Sales Value, 2020-2031
- 5.6.2 Asia Pacific Probiotics for Infants and Women Sales Value by Region (%), 2024 VS 2031
5.7 South America
- 5.7.1 South America Probiotics for Infants and Women Sales Value, 2020-2031
- 5.7.2 South America Probiotics for Infants and Women Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
- 5.8.1 Middle East & Africa Probiotics for Infants and Women Sales Value, 2020-2031
- 5.8.2 Middle East & Africa Probiotics for Infants and Women Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Probiotics for Infants and Women Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Probiotics for Infants and Women Sales Value and Sales Volume
- 6.2.1 Key Countries/Regions Probiotics for Infants and Women Sales Value, 2020-2031
- 6.2.2 Key Countries/Regions Probiotics for Infants and Women Sales Volume, 2020-2031
6.3 United States
- 6.3.1 United States Probiotics for Infants and Women Sales Value, 2020-2031
- 6.3.2 United States Probiotics for Infants and Women Sales Value by Type (%), 2024 VS 2031
- 6.3.3 United States Probiotics for Infants and Women Sales Value by Application, 2024 VS 2031
6.4 Europe
- 6.4.1 Europe Probiotics for Infants and Women Sales Value, 2020-2031
- 6.4.2 Europe Probiotics for Infants and Women Sales Value by Type (%), 2024 VS 2031
- 6.4.3 Europe Probiotics for Infants and Women Sales Value by Application, 2024 VS 2031
6.5 China
- 6.5.1 China Probiotics for Infants and Women Sales Value, 2020-2031
- 6.5.2 China Probiotics for Infants and Women Sales Value by Type (%), 2024 VS 2031
- 6.5.3 China Probiotics for Infants and Women Sales Value by Application, 2024 VS 2031
6.6 Japan
- 6.6.1 Japan Probiotics for Infants and Women Sales Value, 2020-2031
- 6.6.2 Japan Probiotics for Infants and Women Sales Value by Type (%), 2024 VS 2031
- 6.6.3 Japan Probiotics for Infants and Women Sales Value by Application, 2024 VS 2031
6.7 South Korea
- 6.7.1 South Korea Probiotics for Infants and Women Sales Value, 2020-2031
- 6.7.2 South Korea Probiotics for Infants and Women Sales Value by Type (%), 2024 VS 2031
- 6.7.3 South Korea Probiotics for Infants and Women Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
- 6.8.1 Southeast Asia Probiotics for Infants and Women Sales Value, 2020-2031
- 6.8.2 Southeast Asia Probiotics for Infants and Women Sales Value by Type (%), 2024 VS 2031
- 6.8.3 Southeast Asia Probiotics for Infants and Women Sales Value by Application, 2024 VS 2031
6.9 India
- 6.9.1 India Probiotics for Infants and Women Sales Value, 2020-2031
- 6.9.2 India Probiotics for Infants and Women Sales Value by Type (%), 2024 VS 2031
- 6.9.3 India Probiotics for Infants and Women Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 DuPont
- 7.1.1 DuPont Company Information
- 7.1.2 DuPont Introduction and Business Overview
- 7.1.3 DuPont Probiotics for Infants and Women Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.1.4 DuPont Probiotics for Infants and Women Product Offerings
- 7.1.5 DuPont Recent Development
7.2 Novonesis
- 7.2.1 Novonesis Company Information
- 7.2.2 Novonesis Introduction and Business Overview
- 7.2.3 Novonesis Probiotics for Infants and Women Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.2.4 Novonesis Probiotics for Infants and Women Product Offerings
- 7.2.5 Novonesis Recent Development
7.3 Lallemand
- 7.3.1 Lallemand Company Information
- 7.3.2 Lallemand Introduction and Business Overview
- 7.3.3 Lallemand Probiotics for Infants and Women Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.3.4 Lallemand Probiotics for Infants and Women Product Offerings
- 7.3.5 Lallemand Recent Development
7.4 BioGaia
- 7.4.1 BioGaia Company Information
- 7.4.2 BioGaia Introduction and Business Overview
- 7.4.3 BioGaia Probiotics for Infants and Women Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.4.4 BioGaia Probiotics for Infants and Women Product Offerings
- 7.4.5 BioGaia Recent Development
7.5 Probi
- 7.5.1 Probi Company Information
- 7.5.2 Probi Introduction and Business Overview
- 7.5.3 Probi Probiotics for Infants and Women Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.5.4 Probi Probiotics for Infants and Women Product Offerings
- 7.5.5 Probi Recent Development
7.6 Biosearch Life
- 7.6.1 Biosearch Life Company Information
- 7.6.2 Biosearch Life Introduction and Business Overview
- 7.6.3 Biosearch Life Probiotics for Infants and Women Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.6.4 Biosearch Life Probiotics for Infants and Women Product Offerings
- 7.6.5 Biosearch Life Recent Development
7.7 Morinaga Milk Industry
- 7.7.1 Morinaga Milk Industry Company Information
- 7.7.2 Morinaga Milk Industry Introduction and Business Overview
- 7.7.3 Morinaga Milk Industry Probiotics for Infants and Women Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.7.4 Morinaga Milk Industry Probiotics for Infants and Women Product Offerings
- 7.7.5 Morinaga Milk Industry Recent Development
7.8 Synbio Tech
- 7.8.1 Synbio Tech Company Information
- 7.8.2 Synbio Tech Introduction and Business Overview
- 7.8.3 Synbio Tech Probiotics for Infants and Women Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.8.4 Synbio Tech Probiotics for Infants and Women Product Offerings
- 7.8.5 Synbio Tech Recent Development
7.9 Kerry Group
- 7.9.1 Kerry Group Company Information
- 7.9.2 Kerry Group Introduction and Business Overview
- 7.9.3 Kerry Group Probiotics for Infants and Women Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.9.4 Kerry Group Probiotics for Infants and Women Product Offerings
- 7.9.5 Kerry Group Recent Development
7.10 Nestle
- 7.10.1 Nestle Company Information
- 7.10.2 Nestle Introduction and Business Overview
- 7.10.3 Nestle Probiotics for Infants and Women Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.10.4 Nestle Probiotics for Infants and Women Product Offerings
- 7.10.5 Nestle Recent Development
7.11 Yakult
- 7.11.1 Yakult Company Information
- 7.11.2 Yakult Introduction and Business Overview
- 7.11.3 Yakult Probiotics for Infants and Women Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.11.4 Yakult Probiotics for Infants and Women Product Offerings
- 7.11.5 Yakult Recent Development
7.12 Sabinsa
- 7.12.1 Sabinsa Company Information
- 7.12.2 Sabinsa Introduction and Business Overview
- 7.12.3 Sabinsa Probiotics for Infants and Women Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.12.4 Sabinsa Probiotics for Infants and Women Product Offerings
- 7.12.5 Sabinsa Recent Development
7.13 Evivo
- 7.13.1 Evivo Company Information
- 7.13.2 Evivo Introduction and Business Overview
- 7.13.3 Evivo Probiotics for Infants and Women Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.13.4 Evivo Probiotics for Infants and Women Product Offerings
- 7.13.5 Evivo Recent Development
7.14 AB-Biotics
- 7.14.1 AB-Biotics Company Information
- 7.14.2 AB-Biotics Introduction and Business Overview
- 7.14.3 AB-Biotics Probiotics for Infants and Women Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.14.4 AB-Biotics Probiotics for Infants and Women Product Offerings
- 7.14.5 AB-Biotics Recent Development
7.15 Bioflag Group
- 7.15.1 Bioflag Group Company Information
- 7.15.2 Bioflag Group Introduction and Business Overview
- 7.15.3 Bioflag Group Probiotics for Infants and Women Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.15.4 Bioflag Group Probiotics for Infants and Women Product Offerings
- 7.15.5 Bioflag Group Recent Development
7.16 Beijing Scitop Bio-tech
- 7.16.1 Beijing Scitop Bio-tech Company Information
- 7.16.2 Beijing Scitop Bio-tech Introduction and Business Overview
- 7.16.3 Beijing Scitop Bio-tech Probiotics for Infants and Women Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.16.4 Beijing Scitop Bio-tech Probiotics for Infants and Women Product Offerings
- 7.16.5 Beijing Scitop Bio-tech Recent Development
7.17 Hebei Yiran Biological Technology
- 7.17.1 Hebei Yiran Biological Technology Company Information
- 7.17.2 Hebei Yiran Biological Technology Introduction and Business Overview
- 7.17.3 Hebei Yiran Biological Technology Probiotics for Infants and Women Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.17.4 Hebei Yiran Biological Technology Probiotics for Infants and Women Product Offerings
- 7.17.5 Hebei Yiran Biological Technology Recent Development

8 Industry Chain Analysis

8.1 Probiotics for Infants and Women Industrial Chain
8.2 Probiotics for Infants and Women Upstream Analysis
- 8.2.1 Key Raw Materials
- 8.2.2 Raw Materials Key Suppliers
- 8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
- 8.5.1 Probiotics for Infants and Women Sales Model
- 8.5.2 Sales Channel
- 8.5.3 Probiotics for Infants and Women Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology
- 10.1.1 Methodology/Research Approach
  - 10.1.1.1 Research Programs/Design
  - 10.1.1.2 Market Size Estimation
  - 10.1.1.3 Market Breakdown and Data Triangulation
- 10.1.2 Data Source
  - 10.1.2.1 Secondary Sources
  - 10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

List of Tables

Table 1. Probiotics for Infants and Women Market Trends
Table 2. Probiotics for Infants and Women Market Drivers & Opportunity
Table 3. Probiotics for Infants and Women Market Challenges
Table 4. Probiotics for Infants and Women Market Restraints
Table 5. Global Probiotics for Infants and Women Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Probiotics for Infants and Women Revenue Market Share by Company (2020-2025)
Table 7. Global Probiotics for Infants and Women Sales Volume by Company (2020-2025) & (Tons)
Table 8. Global Probiotics for Infants and Women Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Probiotics for Infants and Women Price by Company (2020-2025) & (US$/kg)
Table 10. Key Manufacturers Probiotics for Infants and Women Manufacturing Base and Headquarters
Table 11. Key Manufacturers Probiotics for Infants and Women Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Probiotics for Infants and Women
Table 13. Global Probiotics for Infants and Women Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Probiotics for Infants and Women as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Probiotics for Infants and Women Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Probiotics for Infants and Women Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Probiotics for Infants and Women Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Probiotics for Infants and Women Sales Market Share in Value by Type (2020-2025)
Table 20. Global Probiotics for Infants and Women Sales Market Share in Value by Type (2026-2031)
Table 21. Global Probiotics for Infants and Women Sales Volume by Type: 2020 VS 2024 VS 2031 (Tons)
Table 22. Global Probiotics for Infants and Women Sales Volume by Type (2020-2025) & (Tons)
Table 23. Global Probiotics for Infants and Women Sales Volume by Type (2026-2031) & (Tons)
Table 24. Global Probiotics for Infants and Women Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Probiotics for Infants and Women Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Probiotics for Infants and Women Price by Type (2020-2025) & (US$/kg)
Table 27. Global Probiotics for Infants and Women Price by Type (2026-2031) & (US$/kg)
Table 28. Global Probiotics for Infants and Women Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Probiotics for Infants and Women Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Probiotics for Infants and Women Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Probiotics for Infants and Women Sales Market Share in Value by Application (2020-2025)
Table 32. Global Probiotics for Infants and Women Sales Market Share in Value by Application (2026-2031)
Table 33. Global Probiotics for Infants and Women Sales Volume by Application: 2020 VS 2024 VS 2031 (Tons)
Table 34. Global Probiotics for Infants and Women Sales Volume by Application (2020-2025) & (Tons)
Table 35. Global Probiotics for Infants and Women Sales Volume by Application (2026-2031) & (Tons)
Table 36. Global Probiotics for Infants and Women Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Probiotics for Infants and Women Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Probiotics for Infants and Women Price by Application (2020-2025) & (US$/kg)
Table 39. Global Probiotics for Infants and Women Price by Application (2026-2031) & (US$/kg)
Table 40. Global Probiotics for Infants and Women Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Probiotics for Infants and Women Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Probiotics for Infants and Women Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Probiotics for Infants and Women Sales Value by Region (2020-2025) & (%)
Table 44. Global Probiotics for Infants and Women Sales Value by Region (2026-2031) & (%)
Table 45. Global Probiotics for Infants and Women Sales Volume by Region (Tons): 2020 VS 2024 VS 2031
Table 46. Global Probiotics for Infants and Women Sales Volume by Region (2020-2025) & (Tons)
Table 47. Global Probiotics for Infants and Women Sales Volume by Region (2026-2031) & (Tons)
Table 48. Global Probiotics for Infants and Women Sales Volume by Region (2020-2025) & (%)
Table 49. Global Probiotics for Infants and Women Sales Volume by Region (2026-2031) & (%)
Table 50. Global Probiotics for Infants and Women Average Price by Region (2020-2025) & (US$/kg)
Table 51. Global Probiotics for Infants and Women Average Price by Region (2026-2031) & (US$/kg)
Table 52. Key Countries/Regions Probiotics for Infants and Women Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Probiotics for Infants and Women Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Probiotics for Infants and Women Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Probiotics for Infants and Women Sales Volume, (2020-2025) & (Tons)
Table 56. Key Countries/Regions Probiotics for Infants and Women Sales Volume, (2026-2031) & (Tons)
Table 57. DuPont Company Information
Table 58. DuPont Introduction and Business Overview
Table 59. DuPont Probiotics for Infants and Women Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 60. DuPont Probiotics for Infants and Women Product Offerings
Table 61. DuPont Recent Development
Table 62. Novonesis Company Information
Table 63. Novonesis Introduction and Business Overview
Table 64. Novonesis Probiotics for Infants and Women Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 65. Novonesis Probiotics for Infants and Women Product Offerings
Table 66. Novonesis Recent Development
Table 67. Lallemand Company Information
Table 68. Lallemand Introduction and Business Overview
Table 69. Lallemand Probiotics for Infants and Women Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 70. Lallemand Probiotics for Infants and Women Product Offerings
Table 71. Lallemand Recent Development
Table 72. BioGaia Company Information
Table 73. BioGaia Introduction and Business Overview
Table 74. BioGaia Probiotics for Infants and Women Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 75. BioGaia Probiotics for Infants and Women Product Offerings
Table 76. BioGaia Recent Development
Table 77. Probi Company Information
Table 78. Probi Introduction and Business Overview
Table 79. Probi Probiotics for Infants and Women Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 80. Probi Probiotics for Infants and Women Product Offerings
Table 81. Probi Recent Development
Table 82. Biosearch Life Company Information
Table 83. Biosearch Life Introduction and Business Overview
Table 84. Biosearch Life Probiotics for Infants and Women Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 85. Biosearch Life Probiotics for Infants and Women Product Offerings
Table 86. Biosearch Life Recent Development
Table 87. Morinaga Milk Industry Company Information
Table 88. Morinaga Milk Industry Introduction and Business Overview
Table 89. Morinaga Milk Industry Probiotics for Infants and Women Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 90. Morinaga Milk Industry Probiotics for Infants and Women Product Offerings
Table 91. Morinaga Milk Industry Recent Development
Table 92. Synbio Tech Company Information
Table 93. Synbio Tech Introduction and Business Overview
Table 94. Synbio Tech Probiotics for Infants and Women Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 95. Synbio Tech Probiotics for Infants and Women Product Offerings
Table 96. Synbio Tech Recent Development
Table 97. Kerry Group Company Information
Table 98. Kerry Group Introduction and Business Overview
Table 99. Kerry Group Probiotics for Infants and Women Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 100. Kerry Group Probiotics for Infants and Women Product Offerings
Table 101. Kerry Group Recent Development
Table 102. Nestle Company Information
Table 103. Nestle Introduction and Business Overview
Table 104. Nestle Probiotics for Infants and Women Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 105. Nestle Probiotics for Infants and Women Product Offerings
Table 106. Nestle Recent Development
Table 107. Yakult Company Information
Table 108. Yakult Introduction and Business Overview
Table 109. Yakult Probiotics for Infants and Women Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 110. Yakult Probiotics for Infants and Women Product Offerings
Table 111. Yakult Recent Development
Table 112. Sabinsa Company Information
Table 113. Sabinsa Introduction and Business Overview
Table 114. Sabinsa Probiotics for Infants and Women Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 115. Sabinsa Probiotics for Infants and Women Product Offerings
Table 116. Sabinsa Recent Development
Table 117. Evivo Company Information
Table 118. Evivo Introduction and Business Overview
Table 119. Evivo Probiotics for Infants and Women Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 120. Evivo Probiotics for Infants and Women Product Offerings
Table 121. Evivo Recent Development
Table 122. AB-Biotics Company Information
Table 123. AB-Biotics Introduction and Business Overview
Table 124. AB-Biotics Probiotics for Infants and Women Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 125. AB-Biotics Probiotics for Infants and Women Product Offerings
Table 126. AB-Biotics Recent Development
Table 127. Bioflag Group Company Information
Table 128. Bioflag Group Introduction and Business Overview
Table 129. Bioflag Group Probiotics for Infants and Women Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 130. Bioflag Group Probiotics for Infants and Women Product Offerings
Table 131. Bioflag Group Recent Development
Table 132. Beijing Scitop Bio-tech Company Information
Table 133. Beijing Scitop Bio-tech Introduction and Business Overview
Table 134. Beijing Scitop Bio-tech Probiotics for Infants and Women Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 135. Beijing Scitop Bio-tech Probiotics for Infants and Women Product Offerings
Table 136. Beijing Scitop Bio-tech Recent Development
Table 137. Hebei Yiran Biological Technology Company Information
Table 138. Hebei Yiran Biological Technology Introduction and Business Overview
Table 139. Hebei Yiran Biological Technology Probiotics for Infants and Women Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 140. Hebei Yiran Biological Technology Probiotics for Infants and Women Product Offerings
Table 141. Hebei Yiran Biological Technology Recent Development
Table 142. Key Raw Materials Lists
Table 143. Raw Materials Key Suppliers Lists
Table 144. Probiotics for Infants and Women Downstream Customers
Table 145. Probiotics for Infants and Women Distributors List
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources

List of Figures

Figure 1. Probiotics for Infants and Women Product Picture
Figure 2. Global Probiotics for Infants and Women Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Probiotics for Infants and Women Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Probiotics for Infants and Women Sales Volume (2020-2031) & (Tons)
Figure 5. Global Probiotics for Infants and Women Sales Price (2020-2031) & (US$/kg)
Figure 6. Probiotics for Infants and Women Report Years Considered
Figure 7. Global Probiotics for Infants and Women Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Probiotics for Infants and Women Players Sales Volume Ranking (2024) & (Tons)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Probiotics for Infants and Women Revenue in 2024
Figure 10. Probiotics for Infants and Women Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Lactobacillus Picture
Figure 12. Bifidobacterium Picture
Figure 13. Others Picture
Figure 14. Global Probiotics for Infants and Women Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 15. Global Probiotics for Infants and Women Sales Value Market Share by Type, 2024 & 2031
Figure 16. Global Probiotics for Infants and Women Sales Volume by Type (2020 VS 2024 VS 2031) & (Tons)
Figure 17. Global Probiotics for Infants and Women Sales Volume Market Share by Type, 2024 & 2031
Figure 18. Global Probiotics for Infants and Women Price by Type (2020-2031) & (US$/kg)
Figure 19. Product Picture of Infant
Figure 20. Product Picture of Women
Figure 21. Global Probiotics for Infants and Women Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 22. Global Probiotics for Infants and Women Sales Value Market Share by Application, 2024 & 2031
Figure 23. Global Probiotics for Infants and Women Sales Volume by Application (2020 VS 2024 VS 2031) & (Tons)
Figure 24. Global Probiotics for Infants and Women Sales Volume Market Share by Application, 2024 & 2031
Figure 25. Global Probiotics for Infants and Women Price by Application (2020-2031) & (US$/kg)
Figure 26. North America Probiotics for Infants and Women Sales Value (2020-2031) & (US$ Million)
Figure 27. North America Probiotics for Infants and Women Sales Value by Country (%), 2024 VS 2031
Figure 28. Europe Probiotics for Infants and Women Sales Value, (2020-2031) & (US$ Million)
Figure 29. Europe Probiotics for Infants and Women Sales Value by Country (%), 2024 VS 2031
Figure 30. Asia Pacific Probiotics for Infants and Women Sales Value, (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Probiotics for Infants and Women Sales Value by Region (%), 2024 VS 2031
Figure 32. South America Probiotics for Infants and Women Sales Value, (2020-2031) & (US$ Million)
Figure 33. South America Probiotics for Infants and Women Sales Value by Country (%), 2024 VS 2031
Figure 34. Middle East & Africa Probiotics for Infants and Women Sales Value, (2020-2031) & (US$ Million)
Figure 35. Middle East & Africa Probiotics for Infants and Women Sales Value by Country (%), 2024 VS 2031
Figure 36. Key Countries/Regions Probiotics for Infants and Women Sales Value (%), (2020-2031)
Figure 37. Key Countries/Regions Probiotics for Infants and Women Sales Volume (%), (2020-2031)
Figure 38. United States Probiotics for Infants and Women Sales Value, (2020-2031) & (US$ Million)
Figure 39. United States Probiotics for Infants and Women Sales Value by Type (%), 2024 VS 2031
Figure 40. United States Probiotics for Infants and Women Sales Value by Application (%), 2024 VS 2031
Figure 41. Europe Probiotics for Infants and Women Sales Value, (2020-2031) & (US$ Million)
Figure 42. Europe Probiotics for Infants and Women Sales Value by Type (%), 2024 VS 2031
Figure 43. Europe Probiotics for Infants and Women Sales Value by Application (%), 2024 VS 2031
Figure 44. China Probiotics for Infants and Women Sales Value, (2020-2031) & (US$ Million)
Figure 45. China Probiotics for Infants and Women Sales Value by Type (%), 2024 VS 2031
Figure 46. China Probiotics for Infants and Women Sales Value by Application (%), 2024 VS 2031
Figure 47. Japan Probiotics for Infants and Women Sales Value, (2020-2031) & (US$ Million)
Figure 48. Japan Probiotics for Infants and Women Sales Value by Type (%), 2024 VS 2031
Figure 49. Japan Probiotics for Infants and Women Sales Value by Application (%), 2024 VS 2031
Figure 50. South Korea Probiotics for Infants and Women Sales Value, (2020-2031) & (US$ Million)
Figure 51. South Korea Probiotics for Infants and Women Sales Value by Type (%), 2024 VS 2031
Figure 52. South Korea Probiotics for Infants and Women Sales Value by Application (%), 2024 VS 2031
Figure 53. Southeast Asia Probiotics for Infants and Women Sales Value, (2020-2031) & (US$ Million)
Figure 54. Southeast Asia Probiotics for Infants and Women Sales Value by Type (%), 2024 VS 2031
Figure 55. Southeast Asia Probiotics for Infants and Women Sales Value by Application (%), 2024 VS 2031
Figure 56. India Probiotics for Infants and Women Sales Value, (2020-2031) & (US$ Million)
Figure 57. India Probiotics for Infants and Women Sales Value by Type (%), 2024 VS 2031
Figure 58. India Probiotics for Infants and Women Sales Value by Application (%), 2024 VS 2031
Figure 59. Probiotics for Infants and Women Industrial Chain
Figure 60. Probiotics for Infants and Women Manufacturing Cost Structure
Figure 61. Channels of Distribution (Direct Sales, and Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed